HOME >> MEDICINE >> NEWS
New study shows patients more willing to consider self-injectable HIV therapy than many physicians anticipate

Initial results from the OpenMind study, the largest behavioural study to look at both patients' and physicians' perceptions of HIV care in treatment-experienced patients, were revealed today at EACS. The study's findings are anticipated to help physicians implement improved care to HIV patients and help pave the way for better acceptance and integration of other new innovative drugs such as monoclonal antibodies that are increasingly being developed for the management of HIV and other diseases.

The study was conceived to look at attitudes to FUZEON (enfuvirtide), the first approved HIV fusion inhibitor, and an important option for treatment-experienced patients who face HIV resistance. FUZEON presents unique challenges because it is the first self-injectable antiretroviral whereas all other treatments are oral.

Highlights from today's data show that:

  • Patients are more willing to consider and use self-injectable therapy than many physicians anticipate
  • Three-quarters (76%) of patients would consider using a self-injectable HIV therapy if their physician recommended it
  • Worryingly, only one quarter (28%) of patients who are potentially eligible for FUZEON had actually discussed this injectable option with their physicians
  • Only 10% of eligible patients were currently prescribed FUZEON, despite the fact that it is recommended in key international HIV treatment guidelines

This study also identifies some of the main reasons why many physicians may be reluctant to prescribe a treatment of proven efficacy and safety. The reasons include; the physicians' perception that patients would be reluctant to use a self-injectable therapy, the physicians' opinion that the patient would not be able to incorporate FUZEON into their lifestyle and the potential misconception that FUZEON is not appropriately recommended in guidelines.

"Physicians' best intentions in trying to match treatments t
'"/>

Contact: Kate Pogson
kate.pogson@ketchum.com
44-207-611-3552
Ketchum
18-Nov-2005


Page: 1 2

Related medicine news :

1. Childhood obesity indicates greater risk of school absenteeism, Penn study reveals
2. Penn study finds pro-death proteins required to regulate healthy immune function
3. New study shows promise in reducing surgical risks associated with surgical bleeding
4. New study counts the economic cost of persistent pain in Australia
5. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
6. Most seniors now have drug coverage, U-M study shows
7. To gain muscle and lose fat, drink milk: study
8. Wheres the beef? Not enough of it is on elders plates, muscle-metabolism study suggests
9. Even older women at high risk have little interest in being tested for HIV, study finds
10. Metabolic study in mice could lead to good cholesterol boosters
11. Michigan-CDC study supports value of social restrictions during influenza pandemics

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/5/2016)... ... December 05, 2016 , ... ... blend of L-Citrulline and glutathione to enhance production of nitric oxide (NO). , ... have shown to produce NO twice as effectively and sustains NO blood levels ...
(Date:12/5/2016)... New York, NY (PRWEB) , ... December 05, 2016 , ... ... founder of 5th Avenue Cosmetic Plastic Surgery, who recently participated in the 36th Annual ... be offering five of the newest techniques for getting that perfect, yet natural-looking, nose. ...
(Date:12/5/2016)... ... December 05, 2016 , ... “Life Will Never Be The ... family and friends. “Life Will Never Be The Same” is the creation of published ... writing children's books and holds a degree in Christian religion and philosophy from Judson ...
(Date:12/5/2016)... Diego, CA (PRWEB) , ... December 05, 2016 , ... ... seen and heard the dangers and downsides of patients who do not do their ... The field of cosmetic dermatology is in the midst of a renaissance and every ...
(Date:12/4/2016)... ... December 02, 2016 , ... Metabolic Code ... to nutraceuticals and help doctors more efficiently manage their practice. Power2Practice is ... software platform for Integrative and Functional Medicine. , The Metabolic Code platform ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)...  Wellbridge Health and Gateway Health proudly announce a dynamic ... and Medicaid plan members with specific high risk needs. ... of this group of consumers, Wellbridge combines technology and population ... insight into members, daily behaviors and lifestyle. ... , , ...
(Date:12/5/2016)... R.I. , Dec. 5, 2016  New ... CVS ) Research Institute and the U.S. Department ... Assistant Secretary for Preparedness and Response (ASPR), published ... showed that automated pharmacy notifications encourage patients with ... forecasted natural disaster. The study also affirms that ...
(Date:12/5/2016)... 2016  BD (Becton, Dickinson and Company) (NYSE: ... will demonstrate an enhanced technology platform designed with the ... company,s leading Pyxis™ and Alaris™ systems, at this year,s ... Meeting being held in Las Vegas ... data show that approximately 68 percent of medication errors ...
Breaking Medicine Technology:
Cached News: